TIL Therapies market Research Report by 2023, Forecast till 2035

by Robertclarke

Given the limitations associated with conventional cancer treatment options, there has been a surge in the need for more effective, safe and versatile alternatives, such as TIL-based therapies.

Driven by a promising development pipeline and encouraging clinical trial results, the TIL-based therapy market is likely to carve out a significant share of the cancer immunotherapy market. The financial opportunity within the TIL-based therapy market has been analyzed across the following segments:

 Target Indication(s)
 Melanoma
 Head and Neck Carcinoma
 Chronic Lymphocytic Leukemia
 Sarcoma
 Hepatocellular Carcinoma
 Breast Cancer
 Acute Myeloid Leukemia
 Cervical Carcinoma

 Key Geographical Regions
 North America
 Europe
 Asia Pacific
 Latin America
 Middle East and North Africa
 Rest of the World

The Global TIL Therapy (2nd Edition), 2023-2035 report features the following companies, which we identified to be key players in this domain:
 Cellectis
 Cellular Biomedicine Group
 Iovance Biotherapeutics
 Lytix Biopharma
 Phio Pharmaceuticals

Table of Contents

1. Preface
2. Executive Summary
3. Introduction
4. TIL-based Therapies: Market Landscape
5. Clinical Trial Analysis
6. Key Opinion Leaders
7. TIL-based Therapy Profiles
8. Partnerships And Collaborations
9. Funding And Investment Analysis
10. Patent Analysis
11. Case Study: Cell Therapy Manufacturing
12. Cost Price Analysis
13. Market Forecast and Opportunity Analysis
14. Company Profiles
15. Concluding Remarks
16. Executive Insights
17. Appendix I: Tabulated Data
18. Appendix II: List of Companies and Organizations

To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/til-therapies-market.html

Learn from experts: do you know about these emerging industry trends?
Biopharmaceutical Filtration: A Deep Dive
Rising Demand for DNA and Gene Cloning Service Providers
Exosome Companies Prospering in this Uncertain Market

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

You may also like

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?
-
00:00
00:00
Update Required Flash plugin
-
00:00
00:00